Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.124.034364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Kui Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA. Hauptthemen laut MEDLINE: Apolipoproteins, Biomarkers, Black or African American, Coronary Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NCEH CDC HHS.
Abstract (Originalsprache)
Background Comprehensive blood lipoprotein profiles and their association with incident coronary heart disease (CHD) among racially and geographically diverse populations remain understudied. Methods and Results We conducted nested case–control studies of CHD among 3438 individuals (1719 pairs), including 1084 White Americans (542 pairs), 1244 Black Americans (622 pairs), and 1110 Chinese adults (555 pairs). We examined 36 plasma lipids, lipoproteins, and apolipoproteins, measured by nuclear magnetic resonance spectroscopy, with incident CHD among all participants and subgroups by demographics, lifestyle, and metabolic health status using conditional or unconditional logistic regression adjusted for potential confounders. Conventionally measured blood lipids, that is, total cholesterol, triglycerides, low‐density lipoprotein‐cholesterol, and high‐density lipoprotein‐cholesterol, were each associated with incident CHD, with odds ratios (ORs) being 1.33, 1.32, 1.24, and 0.79 per 1‐SD increase among all participants. Seventeen lipoprotein biomarkers showed numerically stronger associations than conventional lipids, with ORs per 1‐SD among all participants ranging from 1.35 to 1.57 and a negative OR of 0.78 (all false discovery rate
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA.
- Section of Epidemiology and Population Health & Department of Gynecology and Obstetrics, Ministry of Education Key Laboratory of Birth Defects and Related Diseases of Women and Children & National Medical Products Admin…
- Department of Chemistry and Center for Structural Biology Vanderbilt University Nashville TN USA.
- Vanderbilt Translational and Clinical Cardiovascular Research Center and Division of Cardiovascular Medicine, Department of Medicine Vanderbilt University Medical Center Nashville TN USA.
ORCID-Profile: Kui Deng, Xiong-Fei Pan, Markus W Voehler, Qiuyin Cai, Hui Cai, Xiao-Ou Shu, Deepak K Gupta, Loren Lipworth, Wei Zheng, Danxia Yu
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NCEH CDC HHS
- NCRR NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Deng, K., Pan, X. F., Voehler, M. W., Cai, Q., Cai, H., Shu, X. O., Gupta, D. K., Lipworth, L., Zheng, W., & Yu, D. (2024). Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.034364
Vancouver
Deng K, Pan XF, Voehler MW, Cai Q, Cai H, Shu XO, et al. Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.034364
BibTeX
@article{Deng2024,
author = {Deng, Kui and Pan, Xiong-Fei and Voehler, Markus W and Cai, Qiuyin and Cai, Hui and Shu, Xiao-Ou and Gupta, Deepak K and Lipworth, Loren and Zheng, Wei and Yu, Danxia},
title = {Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.124.034364}
}
EUVIMED